Status:
COMPLETED
Evaluation of Astaxanthin Properties on Anti-fatigue
Lead Sponsor:
China Medical University Hospital
Collaborating Sponsors:
National Science and Technology Council
China Medical University, China
Conditions:
Healthy Volunteer
Eligibility:
MALE
20-40 years
Phase:
NA
Brief Summary
Ten young, healthy, physically active male college students were crossed over for AST or placebo supplements randomized into placebo or AST trials and orally consumed placebo or AST (28 mg/d) suppleme...
Detailed Description
AST is composed of two β-ionone ring systems that are linked by a polyene chain and contain oxygenated keto and hydroxyl moieties, which are responsible for its powerful antioxidant activity. AST has ...
Eligibility Criteria
Inclusion
- Recruit people who are healthy are 20-40 years male and have exercise habits in college students
Exclusion
- Have smoking and drinking habits.
- Those who have implanted artificial joints in the past six months and have had recent surgery.
- People who feel unwell due to other reasons during the experiment.
- Take any drugs or Nutrition supplements in the past 3 months.
Key Trial Info
Start Date :
June 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 20 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06593535
Start Date
June 25 2022
End Date
September 20 2022
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University
Taichung, Taiwan, 404332